109 related articles for article (PubMed ID: 17590893)
1. Expanded use of Herceptin.
FDA Consum; 2007; 41(2):4-5. PubMed ID: 17590893
[No Abstract] [Full Text] [Related]
2. From the molecule to the clinic--inhibiting HER2 to treat breast cancer.
Eisenhauer EA
N Engl J Med; 2001 Mar; 344(11):841-2. PubMed ID: 11248162
[No Abstract] [Full Text] [Related]
3. Herceptin (trastuzumab): adjuvant and neoadjuvant trials.
Yaal-Hahoshen N; Safra T
Isr Med Assoc J; 2006 Jun; 8(6):416-21. PubMed ID: 16833172
[No Abstract] [Full Text] [Related]
4. Trastuzumab faces trials, clinical and otherwise.
Tuma RS
J Natl Cancer Inst; 2006 Mar; 98(5):296-8. PubMed ID: 16507822
[No Abstract] [Full Text] [Related]
5. Herceptin: help for advanced breast cancer.
Runowicz CD
Health News; 2001 May; 7(5):4. PubMed ID: 11851153
[No Abstract] [Full Text] [Related]
6. [Breast cancer: adjuvant therapy with trastuzumab: herceptin adjuvant (HERA) Trial Study, B-31- and N9831-Study].
Mallmann P
Internist (Berl); 2006 Nov; 47(11):1183-5. PubMed ID: 17048017
[No Abstract] [Full Text] [Related]
7. Refining therapy for human epidermal growth factor receptor 2-positive breast cancer: T stands for trastuzumab, tumor size, and treatment strategy.
Burstein HJ; Winer EP
J Clin Oncol; 2009 Dec; 27(34):5671-3. PubMed ID: 19884535
[No Abstract] [Full Text] [Related]
8. [Effect of Herceptin combined with Taxol on patients with Her-2/neu overexpressing metastatic breast cancer].
Luo RC; Li AM; Zhang JY; Liao WJ; Ji CY; Miao JX
Zhonghua Zhong Liu Za Zhi; 2004 Jan; 26(1):52-4. PubMed ID: 15059359
[TBL] [Abstract][Full Text] [Related]
9. Trastuzumab before breast surgery? Large trial says yes but does not quell debate.
Rowan K
J Natl Cancer Inst; 2009 Apr; 101(7):448-9. PubMed ID: 19318626
[No Abstract] [Full Text] [Related]
10. [Advances in herceptin neoadjuvant therapy and adjuvant therapy of breast cancer].
Wang LP; Shen KW; Shen ZZ
Zhonghua Zhong Liu Za Zhi; 2006 Apr; 28(4):241-3. PubMed ID: 16875618
[No Abstract] [Full Text] [Related]
11. Herceptin produces clinical benefit in metastatic breast cancer regardless of tumor response.
Oncology (Williston Park); 2004 Aug; 18(9):1201. PubMed ID: 15471203
[No Abstract] [Full Text] [Related]
12. Trastuzumab and breast cancer.
Palmieri C; Powles T; Vigushin D
N Engl J Med; 2001 Sep; 345(13):996-7. PubMed ID: 11575297
[No Abstract] [Full Text] [Related]
13. [Breast cancer].
Tokuda Y; Saito Y; Suzuki Y; Ohta M; Tajima T
Nihon Rinsho; 2002 Mar; 60(3):563-9. PubMed ID: 11904974
[TBL] [Abstract][Full Text] [Related]
14. New developments in adjuvant therapy for breast cancer.
Sledge GW
Clin Adv Hematol Oncol; 2005 Sep; 3(9):688-90. PubMed ID: 16224442
[No Abstract] [Full Text] [Related]
15. [Combination therapy herceptin+taxotere/Herceptin+navelbine].
Meden H
Onkologie; 2002 Dec; 25 Suppl 5():15-6. PubMed ID: 23573614
[No Abstract] [Full Text] [Related]
16. [Systemic pharmacotherapy in breast cancer].
Boér K
Orv Hetil; 2004 Jan; 145(4):187-92. PubMed ID: 14978885
[No Abstract] [Full Text] [Related]
17. Why adjuvant trastuzumab led to better outcomes in women with high-risk HER-2-positive breast cancer.
Altundag K; Baptista MZ
Breast J; 2006; 12(5):497-8. PubMed ID: 16958977
[No Abstract] [Full Text] [Related]
18. Genentech's anticancer Mab expected by November.
Robertson D
Nat Biotechnol; 1998 Jul; 16(7):615. PubMed ID: 9661186
[No Abstract] [Full Text] [Related]
19. [Therapy concept: herceptin in combination with arimidex].
von Minckwitz G
Onkologie; 2002 Dec; 25 Suppl 5():22 ; discussion 22-4. PubMed ID: 23573617
[No Abstract] [Full Text] [Related]
20. [Trastuzumab for treatment of advanced breast cancers].
Watanabe T; Shimizu C; Katsumata N; Saijo N
Nihon Rinsho; 2000 Apr; 58 Suppl():340-4. PubMed ID: 11026016
[No Abstract] [Full Text] [Related]
[Next] [New Search]